Home » Newsletters » BioWorld

BioWorld

Aug. 9, 1994

View Archived Issues

CONNECTIVE THERAPEUTICS EXTENDS GENENTECH AGREEMENT

SANGSTAT BEGINS PHASE III TRIALS FOR KIDNEY REJECTION THERAPY

MOLECULAR BIOSYSTEMS GETS FDA APPROVAL OF IMAGING AGENT FOR HEART

CORRECTION/CLARIFICATION

ALLELIX, FOURNIER WILL RESEARCH ATHEROSCLEROSIS

APOPTOSIS COMPANIES MERGE, RAISE $7.2M IN VENTURE CAPITAL

INDUSTRY OPPOSES SOME PROVISIONS IN MITCHELL'S BILL

10TH INTERNATIONAL CONFERENCE ON AIDS A STRONG REACTION TO INITIAL HIV

ROCHE'S HIVID APPROVED AS MONOTHERAPY